Uncategorized

BaltTech begins monthly tech survey // Baltimore BioWorks applies for minority business certification // BetaPunch unveils new home page [Startup Roundup]

This is the Startup Roundup. Every Wednesday morning, Technically Baltimore will put together the smaller pieces that make up our startup ecosystem. Gus Sentementes, the BaltTech blogger for the Baltimore Sun, has begun a monthly survey where he asks tech companies in Maryland a different question). For the inaugural survey, he asked tech companies what the “number […]

This is the Startup Roundup. Every Wednesday morning, Technically Baltimore will put together the smaller pieces that make up our startup ecosystem.
Gus Sentementes, the BaltTech blogger for the Baltimore Sun, has begun a monthly survey where he asks tech companies in Maryland a different question). For the inaugural survey, he asked tech companies what the “number one issue they face right now.” Responses came from such companies as Mindgrub Technologies and Bizelo (common themes were capital and recruiting). Sentementes has also been collecting information on tech companies in Maryland using a publicly available Google Spreadsheet.

Baltimore BioWorks, which moved into office space at the University of Maryland BioPark’s BioInnovation Center earlier this month, is now applying for “state certification as a Minority Business Enterprise that would allow the life sciences manufacturing and training firm to bid on state contracts that set aside a slice of business for minority- and women-owned companies,” reports Bmore Media. Next month, BioWorks plans to open a 14,000-square-foot production facility.
BetaPunch, the website that connects other startups with beta testers that Technically Baltimore covered yesterday, unveiled a new home page Tuesday. According to the BetaPunch site, more than 250 startups have used the service to recruit beta testers.
Biotech firm Gliknik Inc., founded in 2007 and located in the city’s Hollins Market neighborhood just nearby the University of Maryland BioPark, has $4.8 million committed of a $15 million planned round, according to SEC filings. Gliknik develops “new therapies for patients with cancer and autoimmune/inflammatory diseases,” according to its website.

Companies: BetaPunch
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Donate to the Journalism Fund

Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Trending

When global tech association CompTIA spun off its nonprofit arm, the TechGirlz curriculum went dark

Anne Arundel admits that ransomware attack targeted health data

He watched his tech specialties grow obsolete. But he’s still optimistic about the next frontiers.

Tenable, the Maryland cybersecurity juggernaut, is opening an office in Israel

Technically Media